Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Nutrients|October 21, 2020
Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in WomenSharon M Anderson, Andrea R Thurman, Neelima Chandra, et al.
Eclinicalmedicine|May 27, 2021
Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled TrialAndrea R Thurman, Jill L Schwartz, Mackenzie L Cottrell, et al.
The Journal of Clinical Investigation|September 18, 2018
Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrityIrina A Zalenskaya, Neelima Chandra, Nazita Yousefieh, et al.
Nature Communications|December 2, 2020
Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosisChristina Y Lee, Ryan K Cheu, Melissa M Lemke, et al.
American Journal of Obstetrics and Gynecology|March 4, 2023
ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety studyAndrea R Thurman, Thomas R Moench, Marshall Hoke, et al.
Contemporary Clinical Trials|September 26, 2022
Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019Eleanor McLellan-Lemal, Stacie R Deaton, Joshua E Betts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trialWilliam M Geisler, William D Koltun, Nader Abdelsayed, et al.
Scientific Reports|July 14, 2022
Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in KenyaSmritee Dabee, Nelly Mugo, Victor Mudhune, et al.
Plos One|October 10, 2022
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 studyAndrea R Thurman, Vivian Brache, Leila Cochon, et al.
Frontiers in Reproductive Health|June 29, 2023
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in KenyaNelly R Mugo, Victor Mudhune, Renee Heffron, et al.
Pageof 11